Biochemical Aspects of Therapy-Resistant Depression
- 1 April 1988
- journal article
- review article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 152 (4) , 453-459
- https://doi.org/10.1192/bjp.152.4.453
Abstract
Despite the relatively high incidence of therapy-resistant depression, there is little clinical evidence to suggest that there are significant biochemical differences between therapy-resistant and therapy-responsive patients. A major problem for investigators is the lack of an internationally recognised definition of resistant depression. Also, it is possible that depressed patients with delusional symptoms or rapidly cycling affective disorders form subgroups that are more likely to be resistant to tricylic antidepressant treatment and are therefore classified as therapy-resistant. Evidence is presented to show that an abnormality in serotonergic function may characterise some therapy-resistant depressed patients.Keywords
This publication has 57 references indexed in Scilit:
- Ventricular Size and CSF Transmitter Metabolite Concentrations in Severe Endogenous DepressionThe British Journal of Psychiatry, 1986
- Blood cells as biological trait markers in affective disordersJournal of Psychiatric Research, 1984
- Rapid Response to Lithium in Phenelzine Non-respondersThe British Journal of Psychiatry, 1982
- Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleusLife Sciences, 1980
- Chronic depressive illness.BMJ, 1978
- TOTAL AND NON-BOUND TRYPTOPHAN IN UNIPOLAR ILLNESSThe Lancet, 1976
- Cell contact induces an increase in pinocytotic rate in cultured epithelial cellsNature, 1976
- THE EFFECT OF LITHIUM CARBONATE IN COMBINATION WITH TRICYCLIC ANTIDEPRESSANTS IN ENDOGENOUS DEPRESSION: A double‐blind, multicenter trialActa Psychiatrica Scandinavica, 1974
- TOTAL AND FREE TRYPTOPHAN CONCENTRATION IN THE PLASMA OF DEPRESSIVE PATIENTSThe Lancet, 1973
- PROPHYLACTIC LITHIUM IN AFFECTIVE DISORDERSThe Lancet, 1971